supplemental digital content -...
TRANSCRIPT
1
Drug Safety Preventability of Drug-Related Harms – Part I
A Systematic Review
Ferner RE, Aronson JK
Supplemental Digital Content This Supplemental Digital Content contains the appendix referred to in the full version of this article, which can be found at http://adisonline.com/drugsafety
© 2010 Adis Data Information BV. All rights reserved.
2
Appendix
1. Ackroyd-Stolarz S, Hartnell N, MacKinnon NJ. Demystifying medication safety:
making sense of the terminology. Res Social Adm Pharm 2006; 2(2): 280-9.
2. Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M,
Archimandritis AJ. Adverse drug reactions as a cause of hospital admissions: a 6-
month experience in a single center in Greece. Eur J Intern Med 2008; 19(7): 505-
10.
3. Allen JE. Risk factors and prevention strategies for adverse drug reactions. J Pharm
Care Pain Symptom Control 1995; 3(1): 31-5.
4. Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS. Adverse drug reactions related
hospitalization identified by discharge ICD-9 codes in a university hospital in
Riyadh. Saudi Med J 2008; 29(8): 1145-50.
5. Baena MI, Faus MJ, Fajardo PC, Luque FM, Sierra F, Martinez-Olmos J, Cabrera
A, Fernandez-Llimos F, Martinez-Martinez F, Jimenez J, Zarzuelo A. Medicine-
related problems resulting in emergency department visits. Eur J Clin Pharmacol
2006; 62(5): 387-93.
6. Bailey TC, Noirot LA, Christensen EM, Milligan PE, Kimmel NL, Fraser VJ,
Dunagan WC. Validation of automated event triggers using laboratory values
related to two problem-prone drugs. AMIA Annu Symp Proc 2003: 781.
7. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, Etchells E, Ghali WA,
Hébert P, Majumdar SR, O'Beirne M, Palacios-Derflingher L, Reid RJ, Sheps S,
3
Tamblyn R. The Canadian Adverse Events Study: the incidence of adverse events
among hospital patients in Canada. CMAJ 2004; 170(11): 1678-86.
8. Bartlett G, Blais R, Tamblyn R, Clermont RJ, MacGibbon B. Impact of patient
communication problems on the risk of preventable adverse events in acute care
settings. CMAJ 2008; 178(12): 1555-62.
9. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship
between medication errors and adverse drug events. J Gen Intern Med 1995; 10(4):
199-205.
10. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer
BJ, Shea BF, Hallisey R, Vander Vliet M, Nemeskal R, Leape LL. Incidence of
adverse drug events and potential adverse drug events. Implications for prevention.
ADE Prevention Study Group. JAMA 1995; 274(1): 29-34.
11. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E,
Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL. Effect of computerized
physician order entry and a team intervention on prevention of serious medication
errors. JAMA 1998; 280(15): 1311-6.
12. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug
events in hospitalized adults. J Gen Intern Med 1993; 8(6): 289-94.
13. Bates DW, O'Neil AC, Boyle D, Teich J, Chertow GM, Komaroff AL, Brennan
TA. Potential identifiability and preventability of adverse events using information
systems. J Am Med Inform Assoc 1994; 1(5): 404-11.
4
14. Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma'Luf N, Boyle D, Leape L.
The impact of computerized physician order entry on medication error prevention. J
Am Med Inform Assoc 1999; 6(4): 313-21.
15. Bates DW. Medication errors. How common are they and what can be done to
prevent them? Drug Saf 1996; 15(5): 303-10.
16. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit
criteria for determining inappropriate medication use in nursing home residents.
UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151(9): 1825-32.
17. Beers MH. Explicit criteria for determining potentially inappropriate medication
use by the elderly. An update. Arch Intern Med 1997; 157(14): 1531-6.
18. Beijer HJ, de Blaey CJ Hospitalisations caused by adverse drug reactions (ADR): a
meta-analysis of observational studies. Pharm World Sci 2002; 24(2): 46-54.
19. Bigby J, Dunn J, Goldman L, Adams B, Jen P, Landefeld GS, Komaroff AL.
Assessing the preventability of emergency hospital admissions. Am J Med 1987; 3:
1031-6.
20. Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA. The
epidemiology of prescribing errors: the potential impact of computerized prescriber
order entry. Arch Intern Med 2004; 164(7): 785-92.
21. Brennan TA, Hebert LE, Laird NM, Lawthers A, Thorpe KE, Leape LL, Localio
AR, Lipsitz SR, Newhouse JP, Weiler PC, Hiatt HH. Hospital characteristics
associated with adverse events and substandard care. JAMA 1991; 265(24): 3265-
9.
5
22. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG,
Newhouse JP, Weiler PC, Hiatt HH. Incidence of adverse events and negligence in
hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J
Med 1991; 324(6): 370-6.
23. Buckley MS, Erstad BL, Kopp BJ, Theodorou AA, Priestley G. Direct observation
approach for detecting medication errors and adverse drug events in a pediatric
intensive care unit. Pediatr Crit Care Med 2007; 8(2): 145-52.
24. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to
emergency department visits for adverse drug events in older adults. Ann Intern
Med 2007; 147(11): 755-65.
25. Burkhardt H. Wehling M. Gladisch R. Prävention unerwunschter
Arzneimittelwirkungen bei alteren Patienten. [Prevention of adverse drug reactions
in older patients.] Zeitschrift fur Gerontologie und Geriatrie 2007; 40(4): 241-54.
26. Burnum JF. Preventability of adverse drug reactions. Ann Intern Med 1976; 85(1):
80-1.
27. Calderon-Ospina C, Orozco-Diaz J. Reacciones adversas a medicamentos como
motivo de consulta en un servicio de atencion prioritaria. [Adverse drug reactions
as the reason for visiting an emergency department.] Rev Salud Publica (Bogota)
2008; 10(2): 315-21.
28. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital
admission in the elderly. Intern Med J 2001; 31(4): 199-205.
6
29. Cimino MA, Kirschbaum MS, Brodsky L, Shaha SH; Child Health Accountability
Initiative. Assessing medication prescribing errors in pediatric intensive care units.
Pediatr Crit Care Med 2004; 5(2): 124-32.
30. Committee on Drugs and Committee on Hospital Care. Prevention of medication
errors in the pediatric inpatient setting. American Academy of Pediatrics.
Committee on Drugs and Committee on Hospital Care. Pediatrics 1998; 102(2 Pt
1): 428-30.
31. Cooper JB, Newbower RS, Long CD, McPeek B. Preventable anesthesia mishaps: a
study of human factors. Qual Saf Health Care 2002 Sep; 11(3): 277-82. Reprinted
from Anesthesiology 1978; 49: 399-406.
32. Cousins DD. Developing a uniform reporting system for preventable adverse drug
events. Clin Ther 1998; 20 Suppl C: C45-58.
33. Cresswell KM, Fernando B, McKinstry B, Sheikh A. Adverse drug events in the
elderly. Br Med Bull 2007; 83: 259-74.
34. Cresswell KM, Sheikh A. Information technology-based approaches to reducing
repeat drug exposure in patients with known drug allergies. J Allergy Clin Immunol
2008; 121(5): 1112-7.e7.
35. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The
incident reporting system does not detect adverse drug events: a problem for quality
improvement. Jt Comm J Qual Improv 1995; 21(10): 541-8.
36. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL.
Preventable adverse drug events in hospitalized patients: a comparative study of
intensive care and general care units. Crit Care Med 1997; 25(8): 1289-97.
7
37. Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM. Drug-related
problems in elderly patients admitted to Tayside hospitals, methods for prevention
and subsequent reassessment. Age Ageing 1997; 26(5): 375-82.
38. Cunningham G, Dodd TRP, Grant DJ, McMurdo MET, Richards RME.
Preventability of drug related problems in elderly patients in the community. Pharm
J 1997; 259(6968 Suppl): R2.
39. Curtiss FR. Preventable drug-related morbidity. Preventable drug-related morbidity
(PDRM). J Managed Care Pharm 2003; 9(2): 178.
40. Dago Martinez A. Arcos Gonzalez P. Alvarez de Toledo Saavedra F. Baena Parejo
MI. Martinez Olmos J. Gorostiza Ormaetxe I. Indicadores de riesgo de morbilidad
prevenible. [Risk indicators of preventable morbidity related to drug utilization.]
Gac Sanit 2007; 21(1): 29-36.
41. Darchy B, Le Mière E, Figuérédo B, Bavoux E, Domart Y. Iatrogenic diseases as a
reason for admission to the intensive care unit: incidence, causes, and
consequences. Arch Intern Med 1999; 159(1): 71-8
42. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M.
Adverse drug reactions in hospital in-patients: a prospective analysis of 3695
patient-episodes. PLoS One 2009; 4(2): e4439.
43. Davis P, Lay-Yee R, Briant R, Ali W, Scott A, Schug S. Adverse events in New
Zealand public hospitals. II: preventability and clinical context. N Z Med J 2003;
116(1183): U624.
8
44. Davis P, Lay-Yee R, Briant R, Ali W, Scott A, Schug S. Adverse events in New
Zealand public hospitals I: occurrence and impact. N Z Med J 2002; 115(1167):
U271.
45. Davis P, Lay-Yee R, Briant R, Scott A. Preventable in-hospital medical injury
under the "no fault" system in New Zealand. Qual Saf Health Care 2003; 12(4):
251-6.
46. Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Tröger M, Azaz-
Livshits T, Levy M, Brune K, Hahn EG. Readmissions and adverse drug reactions
in internal medicine: the economic impact. J Intern Med 2004; 255(6): 653-63
47. Doucet J, Jego A, Noel D, Geffroy CE, Capet C, Coquard A, Couffin E, Fauchais
AL, Chassagne P, Mouton-Schleifer D, Bercoff E. Preventable and non-preventable
risk factors for adverse drug events related to hospital admissions in the elderly: a
prospective study. Clin Drug Investig 2002; 22 (6): 385-92.;
48. Ducharme, M M. Boothby, L A. Analysis of adverse drug reactions for
preventability. Int J Clin Pract 2007; 61(1): 157-61.
49. Easton-Carter KL, Chapman CB, Brien JE. Emergency department attendances
associated with drug-related problems in paediatrics. J Paediatr Child Health 2003;
39(2): 124-9.
50. Fernández-Llimós F, Tuneu L, Baena MI, Garcia-Delgado A, Faus MJ.Morbidity
and mortality associated with pharmacotherapy. Evolution and current concept of
drug-related problems. Curr Pharm Des 2004; 10(31): 3947-67.
9
51. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the
Beers criteria for potentially inappropriate medication use in older adults: results of
a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716-24.
52. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC, Auger
JC, Garber LA, Cadoret C, Fish LS, Garber LD, Kelleher M, Bates DW. Risk
factors for adverse drug events among older adults in the ambulatory setting. J Am
Geriatr Soc 2004; 52(8): 1349-54.
53. Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS,
Garber L, Kelleher M, Bates DW. Strategies for detecting adverse drug events
among older persons in the ambulatory setting. J Am Med Inform Assoc 2004;
11(6): 492-8.
54. Flanagan PS, MacKinnon NJ, Bowles SK, Kirkland SA. Validation of four clinical
indicators of preventable drug-related morbidity. Ann Pharmacother 2004; 38(1):
20-4.
55. Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events.
Am J Health Syst Pharm 2004; 61(14): 1466-72.
56. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events
occurring following hospital discharge. J Gen Intern Med 2005; 20(4): 317-23.
57. Forster AJ, Rose NG, van Walraven C, Stiell I. Adverse events following an
emergency department visit. Qual Saf Health Care 2007; 16(1): 17-22.
58. Franceschi M. Scarcelli C. Niro V. Seripa D. Pazienza A.M. Pepe G. Colusso A.M.
Pacilli L. Pilotto A. Prevalence, clinical features and avoidability of adverse drug
10
reactions as cause of admission to a geriatric unit: a prospective study of 1756
patients. Drug Saf 2008; 31(6): 545-56.
59. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to
practice. Int J Qual Health Care 2000; 12(1): 69-76.
60. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL,
Shu K, Federico F, Leape LL, Bates DW. Adverse drug events in ambulatory care.
N Engl J Med 2003; 348(16): 1556-64.
61. Gandhi TK, Weingart SN, Seger AC, Borus J, Burdick E, Poon EG, Leape LL,
Bates DW. Outpatient prescribing errors and the impact of computerized
prescribing. J Gen Intern Med 2005; 20(9): 837-41.
62. García V, Marquina I, Olabarri A, Miranda G, Rubiera G, Baena MI. Resultados
negativos asociados con la medicacion en un servicio de urgencias hospitalario.
[Negative results associated with medication in the emergency department of a
hospital.] Farm Hosp 2008; 32(3): 157-62.
63. Gianino MM, Foti G, Borghese R, Lorelli S, Siliquini R, Renga G. Indicators for
preventable drug-related morbidity. Practical application in home-based care.
Pharmacoepidemiol Drug Saf 2008; 17(5): 501-10.
64. Gosney M, Tallis R.Prescription of contraindicated and interacting drugs in elderly
patients admitted to hospital. Lancet 1984; 2(8402): 564-7.
65. Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G,
Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Bégaud B, Molimard M.
Life-threatening adverse drug reactions at admission to medical intensive care: a
prospective study in a teaching hospital. Intensive Care Med 2007; 33(12): 2150-7.
11
66. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M,
Edmondson AC, Bates DW. Incidence and preventability of adverse drug events in
nursing homes. Am J Med 2000; 109(2): 87-94.
67. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C,
Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse
drug events among older persons in the ambulatory setting. JAMA 2003; 289(9):
1107-16.
68. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, Lee M, White K,
LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Auger J, Bates DW. The
incidence of adverse drug events in two large academic long-term care facilities.
Am J Med 2005; 118(3): 251-8.
69. Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, DeBellis K,
Moldoff J, Verzier N. The safety of warfarin therapy in the nursing home setting.
Am J Med 2007; 120(6): 539-44.
70. Gurwitz JH, Field TS, Rochon P, Judge J, Harrold LR, Bell CM, Lee M, White K,
LaPrino J, Erramuspe-Mainard J, DeFlorio M, Gavendo L, Baril JL, Reed G, Bates
DW. Effect of computerized provider order entry with clinical decision support on
adverse drug events in the long-term care setting. J Am Geriatr Soc 2008; 56(12):
2225-33.
71. Hallas J, Gram LF, Grodum E, Damsbo N, Brøsen K, Haghfelt T, Harvald B, Beck-
Nielsen J, Worm J, Jensen KB, Davidsen O, Frandsen NE, Hagen C, Andersen M,
Frølund F, Kromann-Andersen H, Schou J. Drug related admissions to medical
wards: a population based survey. Br J Clin Pharmacol 1992; 33(1): 61-8.
12
72. Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, Damsbo N. Drug
related hospital admissions: the role of definitions and intensity of data collection,
and the possibility of prevention. J Intern Med 1990; 228(2): 83-90.
73. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM, Schmader
KE. Incidence and predictors of all and preventable adverse drug reactions in frail
elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61(5): 511-
5.
74. Hansen RA, Greene SB, Williams CE, Blalock SJ, Crook KD, Akers R, Carey TS.
Types of medication errors in North Carolina nursing homes: a target for quality
improvement. Am J Geriatr Pharmacother 2006; 4(1): 52-61.
75. Hartwig SC. Siegel J. Schneider PJ. Preventability and severity assessment in
reporting adverse drug reactions. Am J Hosp Pharm 1992; 49(9): 2229-32.
76. Hayward RA, Hofer TP. Estimating hospital deaths due to medical errors:
preventability is in the eye of the reviewer. JAMA 2001; 286(4): 415-20.
77. Holdsworth MT, Fichtl RE, Raisch DW, Hewryk A, Behta M, Mendez-Rico E,
Wong CL, Cohen J, Bostwick S, Greenwald BM. Impact of computerized
prescriber order entry on the incidence of adverse drug events in pediatric
inpatients. Pediatrics 2007; 120(5): 1058-66.
78. Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a
hospital in Scotland. Pharm World Sci 2008; 30(6): 854-62.
79. Howard RL, Avery AJ, Howard PD, Partridge M. Investigation into the reasons for
preventable drug related admissions to a medical admissions unit: observational
study. Qual Saf Health Care 2003; 12(4): 280-5.
13
80. Hwang SH, Lee S, Koo HK, Kim Y. Evaluation of a computer-based adverse-drug-
event monitor. Am J Health Syst Pharm 2008; 65(23): 2265-72.
81. Imbs JL, Pletan Y, Spriet A. Evaluation de la iatrogénèse médicamenteuse évitable:
méthodologie. [Assessment of preventable iatrogenic drug therapy: methodology.
Round Table No 2 at Giens XIII.] Therapie 1998; 53: 365-70
82. MacKinnon NJ, Hepler CD. Preventable drug-related morbidity in older adults 1.
Indicator development. J Manag Care Pharm 2002; 8(5): 365-71.
83. Jain S, Basu S, Parmar VR. Medication errors in neonates admitted in intensive
care unit and emergency department. Indian J Med Sci 2009; 63(4): 145-51.
84. Jönsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hägg S.
Preventable drug related mortality in a Swedish population. Pharmacoepidemiol
Drug Saf 2010; 19(2): 211-5.
85. Jonville-Béra AP, Saissi H, Bensouda-Grimaldi L, Beau-Salinas F, Cissoko H,
Giraudeau B, Autret-Leca E. Avoidability of adverse drug reactions spontaneously
reported to a French regional drug monitoring centre. Drug Saf 2009; 32(5): 429-
40.
86. Joshua L, Devi P, Guido S. Adverse drug reactions in medical intensive care unit of
a tertiary care hospital. Pharmacoepidemiol Drug Saf 2009; 18(7): 639-45.
87. Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R.
Nature of preventable adverse drug events in hospitals: a literature review. Am J
Health Syst Pharm 2003; 60(17): 1750-9.
14
88. Kaushal R, Bates DW, Abramson EL, Soukup JR, Goldmann DA. Unit-based
clinical pharmacists' prevention of serious medication errors in pediatric inpatients.
Am J Health Syst Pharm 2008; 65(13): 1254-60.
89. Kelly WN. Potential risks and prevention. Part 1: Fatal adverse drug events. Am J
Health Syst Pharm 2001; 58(14): 1317-24.
90. Kelly WN. Potential risks and prevention. Part 2: Drug-induced permanent
disabilities. Am J Health Syst Pharm 2001; 58(14): 1325-9.
91. Kelly WN. Potential risks and prevention. Part 4: Reports of significant adverse
drug events. Am J Health Syst Pharm 2001; 58(15): 1406-12.
92. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with
hospitalisation and mortality: a population-based study of the very old. Drugs
Aging 2005; 22(1): 69-82.
93. Kopp BJ, Erstad BL, Allen ME, Theodorou AA, Priestley G. Medication errors and
adverse drug events in an intensive care unit: direct observation approach for
detection. Crit Care Med 2006; 34(2): 415-25.
94. Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J,
Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature.
Drug Saf 2007; 30(5): 379-407.
95. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding
teams reduce preventable adverse drug events in hospital general medicine units.
Arch Intern Med 2003; 163(17): 2014-8.
96. Kunac DL, Kennedy J, Austin N, Reith D. Incidence, preventability, and impact of
Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New
15
Zealand: a prospective observational cohort study. Paediatr Drugs 2009; 11(2):
153-60.
97. Kunac DL, Reith DM, Kennedy J, Austin NC, Williams SM. Inter- and intra-rater
reliability for classification of medication related events in paediatric inpatients.
Qual Saf Health Care 2006; 15(3): 196-201.
98. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal
intensive care. Drug Saf 2005; 28(3): 251-61.
99. Kunac DL, Reith DM. Preventable medication-related events in hospitalised
children in New Zealand. N Z Med J 2008; 121(1272): 17-32.
100. Kuo GM, Phillips RL, Graham D, Hickner JM. Medication errors reported by US
family physicians and their office staff. Qual Saf Health Care 2008; 17(4): 286-90.
101. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Adverse drug
reactions in a department of systemic diseases-oriented internal medicine:
prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 2000;
56(2): 181-6.
102. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, Hallisey R,
Ives J, Laird N, Laffel G, Nemeskal R, Petersen LA, Porter K, Servi D, Shea BF,
Small SD, Sweitzer BJ, Thompson BT, Vander Vliet M; for the ADE Prevention
Study Group. Systems analysis of adverse drug events. ADE Prevention Study
Group. JAMA 1995; 274(1): 35-43.
103. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, Bates
DW. Pharmacist participation on physician rounds and adverse drug events in the
intensive care unit. JAMA 1999; 282(3): 267-70.
16
104. Leape LL, Lawthers AG, Brennan TA, Johnson WG. Preventing medical injury.
QRB Qual Rev Bull 1993; 19(5): 144-9.
105. Lehmann CU, Kim GR. Prevention of medication errors. Clin Perinatol 2005;
32(1): 107-23, vii.
106. Lepori V, Perren A, Marone C. Unerwünschte internmedizinische
Arzneimittelwirkungen bei Spitaleintritt. [Adverse internal medicine drug effects at
hospital admission.] Schweiz Med Wochenschr 1999; 129(24): 915-22.
107. MacKinnon NJ, Hepler CD. Indicators of preventable drug-related morbidity in
older adults. 2. Use within a managed care organization. J Manag Care Pharm
2003; 9(2): 134-41.
108. Marcellino K, Kelly WN. Potential risks and prevention, Part 3: Drug-induced
threats to life. Am J Health Syst Pharm 2001; 58(15): 1399-405.
109. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse
drug reactions. Ann Pharmacother 2002; 36(9): 1331-6.
110. Melmon KL. Preventable drug reactions—causes and cures. N Engl J Med 1971;
284(24): 1361-8.
111. Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients
in Australia. Med J Aust 2006; 184(7): 321-4.
112. Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm BE, Wahlin A, Dahlqvist
R. Adverse drug reactions as a cause for admissions to a department of internal
medicine. Pharmacoepidemiol Drug Saf 2002; 11(1): 65-72.
17
113. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse
drug reactions in a department of general medicine. Br J Clin Pharmacol 1998;
45(3): 301-8.
114. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events
and medication errors: detection and classification methods. Qual Saf Health Care
2004; 13(4): 306-14.
115. Morris CJ, Cantrill JA, Avery AJ, Howard RL. Preventing drug related morbidity: a
process for facilitating changes in practice. Qual Saf Health Care 2006; 15(2): 116-
21.
116. Morris CJ, Cantrill JA, Hepler CD, Noyce PR. Preventing drug-related morbidity—
determining valid indicators. Int J Qual Health Care 2002; 14(3): 183-98.
117. Morris CJ, Cantrill JA. Preventing drug-related morbidity—the development of
quality indicators. J Clin Pharm Ther 2003 Aug; 28(4): 295-305.
118. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug
events and medication errors in outpatients with cardiovascular disease. Arch Intern
Med 2009; 169(8): 757-63.
119. Olivier P, Caron J, Haramburu F, Imbs JL, Jonville-Béra AP, Lagier G, Sgro C,
Vial T, Montastruc JL, Lapeyr-Mestre M. Therapie. Validation d’une échelle de
mesure: exemple de l'échelle française d'évitabilité des effets indésirables
medicamenteux. [Validation of a measurement scale: example of a French Adverse
Drug Reactions Preventability Scale.] 2005; 60(1): 39-45.
120. Olivier P. Boulbes O. Tubery M. Carles P. Montastruc J.L. Lapeyre-Mestre M.
Evitabilité des effets indésirables dans un service d’admissions médicales.
18
[Preventability of adverse effects in a medical emergency service.] Therapie 2001;
56: 275-8.
121. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need
for new criteria. Age Ageing 2008; 37(2): 138-41.
122. Otero López MJ, Alonso Hernández P, Maderuelo Fernández JA, Ceruelo Bermejo
J, Domínguez-Gil Hurlé A, Sánchez Rodríguez A. Prevalencia y factores asociados
a los acontecimientos adversos prevenibles por medicamentos que causan el
ingreso hospitalario. [Prevalence and factors associated with preventable adverse
drug events leading to hospital admission.] Farm Hosp 2006; 30(3): 161-70.
123. Otero López MJ, Bajo Bajo A, Maderuelo Fernández JA, Domínguez-Gil Hurlé A.
Evitabilidad de los acontecimientos adversos inducidos por medicamentos
detectados en un Servicio de Urgencias. [Preventable adverse drug effects at an
emergency department.] Rev Clin Esp 1999; 199(12): 796-805.
124. Otero-López MJ, Alonso-Hernández P, Maderuelo-Fernández JA, Garrido-Corro B,
Domínguez-Gil A, Sánchez-Rodríguez A. Acontecimientos adversos prevenibles
causados por medicamentos en pacientes hospitalizados. [Preventable adverse drug
events in hospitalized patients.] Med Clin (Barc) 2006; 126(3): 81-7.
125. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly
hospitalised population: inappropriate prescription is a leading cause. Drugs Aging
2005; 22(9): 767-77.
126. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation
of the prevalence and economic burden of adverse drug reactions presenting to the
19
medical emergency department of a tertiary referral centre: a prospective study.
BMC Clin Pharmacol 2007; 7: 8
127. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation
of the prevalence and economic burden of adverse drug reactions presenting to the
medical emergency department of a tertiary referral centre: a prospective study.
BMC Clin Pharmacol 2007; 7: 8.
128. Pearson TF, Pittman DG, Longley JM, Grapes T, Vigliotti DJ, Mullis SR. Factors
associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51:
2268-72.
129. Peyriere H, Cassan S, Floutard E, Riviere S, Blayac JP, Hillaire-Buys D, Le
Quellec A, Hansel S. Adverse drug events associated with hospital admission. Ann
Pharmacother 2003; 37(1): 5-11.
130. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park
BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital:
prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-19.
131. Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A,
Kazemnejad A, Moin M. Adverse drug reactions in patients in an Iranian
department of internal medicine. Pharmacoepidemiol Drug Saf 2009; 18(2): 104-
10.
132. Pronovost PJ, Thompson DA, Holzmueller CG, Lubomski LH, Morlock LL.
Defining and measuring patient safety. Crit Care Clin 2005; 21(1): 1-19
133. Prudent M, Dramé M, Jolly D, Trenque T, Parjoie R, Mahmoudi R, Lang PO,
Somme D, Boyer F, Lanièce I, Gauvain JB, Blanchard F, Novella JL. Potentially
20
inappropriate use of psychotropic medications in hospitalized elderly patients in
France: cross-sectional analysis of the prospective, multicentre SAFEs cohort.
Drugs Aging 2008; 25(11): 933-46.
134. Queneau P, Bergmann JF. Prévention de la iatrogénie évitable: quand la sécurité
des maladies se conjugue avec les économies de santé. [Prevention of avoidable
iatrogenic disease: when patient safety joins with health care economics.] Therapie
2001; 56(2): 163-8.
135. Queneau P. Adnet F. Bannwarth B. Carpentier F. Bouget J. Trinh-Duc A.
Emergency-department visits cause by adverse-drug events: Incidence in a French
survey; preventability and useless costs. JEUR 2008; 21(1): 22-8.
136. Queneau P. Trombert B. Carpentier F. Trinh-Duc A. Bannwarth B. Bouget J.
Adverse drug effects: a prospective study by Apnet performed in seven emergency
care units in France: propositions for preventive measures. Ann Pharm Fr 2005;
63(2): 131-42.
137. Queneau, P. Grandmottet P. Prévention de la iatrogénie evitable: le devior de
vigilance. [Prevention of avoidable iatrogenic effects: the obligation for vigilance.]
Presse Med 1998; 27(25): 1280-2.
138. Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P,
La Guidara C. Suspected adverse drug events requiring emergency department
visits or hospital admissions. Eur J Clin Pharmacol 1999; 54(12): 959-63.
139. Rivkin A. Admissions to a medical intensive care unit related to adverse drug
reactions. Am J Health Syst Pharm 2007; 64(17): 1840-3
21
140. Robertson HA, MacKinnon NJ. Development of a list of consensus-approved
clinical indicators of preventable drug-related morbidity in older adults. Clin Ther
2002; 24(10): 1595-613.
141. Rothschild JM, Bates DW, Leape LL. Preventable medical injuries in older
patients. Arch Intern Med 2000; 160(18): 2717-28.
142. Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW.
Analysis of medication-related malpractice claims: causes, preventability, and
costs. Arch Intern Med 2002; 162(21): 2414-20.
143. Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E,
Stone PH, Lilly CM, Katz JT, Czeisler CA, Bates DW. The Critical Care Safety
Study: the incidence and nature of adverse events and serious medical errors in
intensive care. Crit Care Med 2005; 33(8): 1694-700.
144. Rothschild JM, Mann K, Keohane CA, Williams DH, Foskett C, Rosen SL,
Flaherty L, Chu JA, Bates DW. Medication safety in a psychiatric hospital. Gen
Hosp Psychiatry 2007; 29(2): 156-62.
145. Ruiz B, García M, Aguirre U, Aguirre C. Factors predicting hospital readmissions
related to adverse drug reactions. Eur J Clin Pharmacol 2008; 64(7): 715-22.
146. Sánchez Muñoz LA, Castiella Herrero J, Sanjuán Portugal FJ, Naya Manchado J,
Alfaro Alfaro MJ. Utilidad del CMBD para la detección de acontecimientos
adversos por medicamentos. [Usefulness of MBDS in detection of adverse drug
events.] An Med Interna 2007; 24(3): 113-9.
22
147. Sari AB, Cracknell A, Sheldon TA. Incidence, preventability and consequences of
adverse events in older people: results of a retrospective case-note review. Age
Ageing 2008; 37(3): 265-9.
148. Schnurrer JU, Frölich JC. Zur Häufigkeit und Vermeidbarkeit von tödlichen
unerwünschten Arzneimittelwirkungen. [Incidence and prevention of lethal
undesirable drug effects.] Internist (Berl) 2003; 44(7): 889-95.
149. Schumock G.T. Thornton J.P. Focusing on the preventability of adverse drug
reactions. Hosp Pharm 1992; 27(6): 538.
150. Senst BL, Achusim LE, Genest RP, Cosentino LA, Ford CC, Little JA, Raybon SJ,
Bates DW. Practical approach to determining costs and frequency of adverse drug
events in a health care network. Am J Health Syst Pharm 2001; 58(12): 1126-32.
151. Sharifzadeh M, Rasoulinejad M, Valipour F, Nouraie M, Vaziri S. Evaluation of
patient-related factors associated with causality, preventability, predictability and
severity of hepatotoxicity during antituberculosis treatment. Pharmacol Res 2005;
51(4): 353-8.
152. Singh R, McLean-Plunckett EA, Kee R, Wisniewski A, Cadzow R, Okazaki S, Fox
C, Singh G. Experience with a trigger tool for identifying adverse drug events
among older adults in ambulatory primary care. Qual Saf Health Care 2009; 18(3):
199-204.
153. Snyder RA, Abarca J, Meza JL, Rothschild JM, Rizos A, Bates DW. Reliability
evaluation of the adapted national coordinating council medication error reporting
and prevention (NCC MERP) index. Pharmacoepidemiol Drug Saf 2007; 16(9):
1006-13.
23
154. Sotoca Momblona JM, Canivell Fusté S, Alemany Vilches L, Sisó Almirall A,
Codina Jané C, Ribas Sala J. Problemas relacionados con la medicación que causan
ingresos hospitalarios. Aten Prim 2009; 41(3): 141-6.
155. Strandell J, Bate A, Lindquist M, Edwards IR; Swedish, Finnish, Interaction X-
referencing Drug-drug Interaction Database (SFINX Group). Drug-drug
interactions—a preventable patient safety issue? Br J Clin Pharmacol 2008; 65(1):
144-6.
156. Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ. Development, testing,
and findings of a pediatric-focused trigger tool to identify medication-related harm
in US children's hospitals. Pediatrics 2008; 121(4): e927-35.
157. Tam KW, Kwok KH, Fan YM, Tsui KB, Ng KK, Ho KY, Lau KT, Chan YC, Tse
CW, Lau CM. Detection and prevention of medication misadventures in general
practice. Int J Qual Health Care 2008; 20(3): 192-9.
158. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and
preventability of adverse drug reactions in paediatric patients. Drug Saf 2004;
27(11): 819-29.
159. The Canadian Adverse Events Study. The Canadian Adverse Events Supplement.
www.cmaj.ca/cgi/content/full/170/11/1678/DC1
160. Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in
elderly patients: population based review of medical records. BMJ 2000;
320(7237): 741-4.
24
161. van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJ, Verhamme KM, Stricker
BH, Sturkenboom MC. Adverse drug reaction-related hospitalisations: a
population-based cohort study. Pharmacoepidemiol Drug Saf 2008; 17(4): 365-71.
162. van Doormaal JE, Mol PG, van den Bemt PM, Zaal RJ, Egberts AC, Kosterink JG,
Haaijer-Ruskamp FM. Reliability of the assessment of preventable adverse drug
events in daily clinical practice. Qual Saf Health Care 2009; 18(1): 22-7.
163. van Doormaal JE, van den Bemt PM, Mol PG, Zaal RJ, Egberts AC, Haaijer-
Ruskamp FM, Kosterink JG. Medication errors: the impact of prescribing and
transcribing errors on preventable harm in hospitalised patients. Qual Saf Health
Care 2009; 18(1): 22-7.
164. von Laue NC, Schwappach DL, Koeck CM. The epidemiology of preventable
adverse drug events: a review of the literature. Wien Klin Wochenschr 2003;
115(12): 407-15.
165. Wang J.K. Herzog N.S. Kaushal R. Park C. Mochizuki C. Weingarten S.R.
Prevention of pediatric medication errors by hospital pharmacists and the potential
benefit of computerized physician order entry. Pediatrics 2007; 119(1): e77-85.
166. Wawruch M, Zikavska M, Wsolova L, Kuzelova M, Kahayova K, Strateny K,
Kristova V. Adverse drug reactions related to hospital admission in Slovak elderly
patients. Arch Gerontol Geriatr 2009; 48(2): 186-90.
167. Winterstein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. Identifying
clinically significant preventable adverse drug events through a hospital's database
of adverse drug reaction reports. Am J Health Syst Pharm 2002; 59(18): 1742-9.
25
168. Winterstein AG, Johns TE, Rosenberg EI, Hatton RC, Gonzalez-Rothi R,
Kanjanarat P. Nature and causes of clinically significant medication errors in a
tertiary care hospital. Am J Health Syst Pharm 2004; 61(18): 1908-16.
169. Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital
admissions. Ann Pharmacother 2002; 36(7-8): 1238-48.
170. Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable
adverse events in children. Pediatrics 2005; 115(1): 155-60.
171. Zandieh SO, Goldmann DA, Keohane CA, Yoon C, Bates DW, Kaushal R. Risk
factors in preventable adverse drug events in pediatric outpatients. J Pediatr 2008;
152(2): 225-31
172. Zed PJ, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur
K, Wiens MO, Samoy LJ, Lacaria K, Purssell RA. Incidence, severity and
preventability of medication-related visits to the emergency department: a
prospective study. CMAJ 2008; 178(12): 1563-9.